Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lurie Joins FDA: Critic Of Agency, Industry Will Help Make Regulatory Policy

This article was originally published in The Gray Sheet

Executive Summary

One of the most outspoken critics of the device industry and FDA's device center has been named to a top-level position within the agency
Advertisement

Related Content

FDA Counselor Taylor Named Acting Deputy As Hamburg Mulls Reorganization
FDA Counselor Taylor Named Acting Deputy As Hamburg Mulls Reorganization
Regulatory News In Brief
Reimbursement In Brief
Internal FDA Menaflex Investigation Finds Serious Process Deviations
Internal FDA Menaflex Investigation Finds Serious Process Deviations
Congress, FDA Commissioner Question Device Pre-Market Review Process
FDA Panel Gives Thumbs Up To DuraSeal Xact Spine Surgery Sealant
GAO Report On 510(k) Program Calls For Regulations On 20 Device Types
Scrutinizing 510(k)s: Critical Voices Get Heard In Congress

Topics

Advertisement
UsernamePublicRestriction

Register

MT028084

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel